Product Information
GENOTROPIN MINIQUICK 0.4 MG is a brand product labeled by Pfizer Inc., priced at $61.6398 per EA under NDC 00013265002. Its NADAC has been published 129 times since Apr 17, 2024.
Manufacturer
Pfizer Inc.NDC
00013265002
Classification
Brand
Dosage Form
KIT
Effective Date
1/1/2026
Approval Type
Biologic (BLA)
FDA Application
BLA020280On Market Since
12/20/1995
Price Statistics
The NADAC for GENOTROPIN MINIQUICK 0.4 MG has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 4.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $61.6398 per EA |
|---|---|
| All-time high | $61.6398 (Sep 30, 2026) |
| All-time low | $58.6833 (Dec 18, 2024) |
| 52-week high | $61.6398 |
| 52-week low | $59.8305 |
| Median price | $60.0917 |
| Average price | $60.1545 |
| Largest weekly change | +3.0% (Dec 31, 2025) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 50% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pfizer Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
somatropin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GENOTROPIN MINIQUICK 0.4 MG?
The current National Average Drug Acquisition Cost (NADAC) for GENOTROPIN MINIQUICK 0.4 MG, manufactured by Pfizer Inc., is $61.6398 per EA (NDC 00013265002), effective Sep 30, 2026.
How has the price of GENOTROPIN MINIQUICK 0.4 MG changed over time?
Over the history we have for it, the NADAC for GENOTROPIN MINIQUICK 0.4 MG has risen 4.7%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for GENOTROPIN MINIQUICK 0.4 MG?
Since Apr 17, 2024, the NADAC for GENOTROPIN MINIQUICK 0.4 MG has ranged from a low of $58.6833 (Dec 18, 2024) to a high of $61.6398 (Sep 30, 2026), with a median of $60.0917 per EA.
Are there cheaper alternatives to GENOTROPIN MINIQUICK 0.4 MG?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GENOTROPIN MINIQUICK 0.2 MG, is $30.8987 per EA — about 50% below GENOTROPIN MINIQUICK 0.4 MG.
Who manufactures GENOTROPIN MINIQUICK 0.4 MG?
GENOTROPIN MINIQUICK 0.4 MG (NDC 00013265002) is labeled by Pfizer Inc., and CMS classifies it as a brand product.